4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine

C26H25N5O2 — CID 163592421

IUPAC4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine
SMILESC[C@H]1N=C(c2ncc(C3=CCc4ncc(N5CCOCC5)cc43)cn2)O[C@H]1c1ccccc1
InChIInChI=1S/C26H25N5O2/c1-17-24(18-5-3-2-4-6-18)33-26(30-17)25-28-14-19(15-29-25)21-7-8-23-22(21)13-20(16-27-23)31-9-11-32-12-10-31/h2-7,13-17,24H,8-12H2,1H3/t17-,24-/m1/s1
InChIKeyVIOITPNPLZZSGI-MZNJEOGPSA-N
MW439.52 g/mol
LogP3.60
Rot. Bonds4

About 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine

4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine (PubChem CID 163592421) has the molecular formula C26H25N5O2 and a molecular weight of 439.52 g/mol. Its IUPAC name is 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine.

Molecular Properties

Compound Name4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine
PubChem CID163592421
Molecular FormulaC26H25N5O2
Molecular Weight439.52 g/mol
Exact Mass439.20
IUPAC Name4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine
SMILESC[C@H]1N=C(c2ncc(C3=CCc4ncc(N5CCOCC5)cc43)cn2)O[C@H]1c1ccccc1
InChIInChI=1S/C26H25N5O2/c1-17-24(18-5-3-2-4-6-18)33-26(30-17)25-28-14-19(15-29-25)21-7-8-23-22(21)13-20(16-27-23)31-9-11-32-12-10-31/h2-7,13-17,24H,8-12H2,1H3/t17-,24-/m1/s1
InChIKeyVIOITPNPLZZSGI-MZNJEOGPSA-N
XLogP3.60
TPSA72.73 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500439.52
LogP ≤ 53.60
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine?
The IUPAC name of 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine (CID 163592421) is 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine.
What is the SMILES notation for 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine?
The canonical SMILES for 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine is C[C@H]1N=C(c2ncc(C3=CCc4ncc(N5CCOCC5)cc43)cn2)O[C@H]1c1ccccc1.
What is the InChIKey of 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine?
The InChIKey is VIOITPNPLZZSGI-MZNJEOGPSA-N. The full InChI is InChI=1S/C26H25N5O2/c1-17-24(18-5-3-2-4-6-18)33-26(30-17)25-28-14-19(15-29-25)21-7-8-23-22(21)13-20(16-27-23)31-9-11-32-12-10-31/h2-7,13-17,24H,8-12H2,1H3/t17-,24-/m1/s1.
What are the key properties of 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine?
4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine has a molecular weight of 439.52 g/mol, XLogP of 3.60, 4 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-[2-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyrimidin-5-yl]-7H-cyclopenta[b]pyridin-3-yl]morpholine is sourced from PubChem (CID 163592421), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).